Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $40.9 million.

  • Puma Biotechnology's Short-term Investments rose 3869.73% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 3869.73%. This contributed to the annual value of $31.7 million for FY2024, which is 17960.19% up from last year.
  • As of Q3 2025, Puma Biotechnology's Short-term Investments stood at $40.9 million, which was up 3869.73% from $41.4 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Short-term Investments high stood at $41.4 million for Q2 2025, and its period low was $3.2 million during Q3 2023.
  • In the last 5 years, Puma Biotechnology's Short-term Investments had a median value of $19.1 million in 2021 and averaged $20.6 million.
  • As far as peak fluctuations go, Puma Biotechnology's Short-term Investments crashed by 7431.88% in 2022, and later soared by 81241.87% in 2024.
  • Over the past 5 years, Puma Biotechnology's Short-term Investments (Quarter) stood at $19.0 million in 2021, then tumbled by 74.32% to $4.9 million in 2022, then surged by 133.0% to $11.4 million in 2023, then skyrocketed by 179.6% to $31.7 million in 2024, then grew by 28.72% to $40.9 million in 2025.
  • Its Short-term Investments stands at $40.9 million for Q3 2025, versus $41.4 million for Q2 2025 and $30.1 million for Q1 2025.